Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.

@article{Relling2013ClinicalPI,
  title={Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.},
  author={Mary V. Relling and Eric E. Gardner and W J Sandborn and Kjeld Schmiegelow and C. H. Pui and Sook Wah Yee and Charles M. Stein and Melissa Carrillo and William E. Evans and J. Kevin Hicks and M Schwab and Teri E. Klein},
  journal={Clinical pharmacology and therapeutics},
  year={2013},
  volume={93 4},
  pages={324-5}
}
The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Methyltransferase Genotype and Thiopurine Dosing was originally published in March 2011. We reviewed recent literature and concluded that although relevant new evidence has been generated, none of the evidence would change the primary dosing recommendations in the original guideline; therefore, the original publication remains clinically current. Up-to-date information on thiopurine methyltransferase (TPMT… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS
67 Citations
5 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 67 extracted citations

References

Publications referenced by this paper.
Showing 1-5 of 5 references

Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

  • M. V. Relling, Klein, T. E. CPIC
  • Clin. Pharmacol. Ther. 89, 464–467
  • 2011

lessons from the TPMT polymorphism

  • E. Krynetski, Evans, W. E. Drug methylation in cancer therapy
  • Oncogene 22, 7403–7413
  • 2003

Similar Papers

Loading similar papers…